Skip to content

Innoviva Inc Sustainability Reports

Innoviva, Inc. operates as a diversified biopharmaceutical company that manages a core portfolio of royalties from respiratory therapies and develops critical care healthcare assets.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 549300ACOX4QTBES6535

FIGI: BBG001SF23V0

6 reports from 2017 to 2025